Veracyte, Inc.

Healthcare · Diagnostics & Research · United States

Last price 50.01 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.02B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its n...